Does aripiprazole protect from serotonin syndrome?

Psychiatria Danubina

Volumn 24, Issue 1, 2012, Pages 100-101

  Rittmannsberger, Hans ^a   Werl, Regina ^a  

^a Wagner Jauregg State Psychiatric Hospital   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CYTOCHROME P450 2D6; FLUOXETINE; SEROTONIN RECEPTOR; VENLAFAXINE;

ADULT; BORDERLINE STATE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; HUMAN; LETTER; RECEPTOR AFFINITY; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; BORDERLINE PERSONALITY DISORDER; CYCLOHEXANOLS; CYTOCHROME P-450 CYP2D6; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; PIPERAZINES; QUINOLONES; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TREMOR; YOUNG ADULT;

EID: 84860817554     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. Birmes P, Coppin D, Schmitt L, Lauque D: Serotonin syndrome: a brief review. CMAJ 2003; 168:1439-42. (Pubitemid 36714045)
2. Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 2005; 352:1112-20.
3. Buckley PF: Receptor-binding profiles of antipsychotics: clinical strategies when switching between agents. J Clin Psychiatry 2007; 68 (suppl 6):5-9.
4. Dagtekin O, Marcus H, Müller C, Böttiger BW, Spöhr F: Lipid therapy for serotonin syndrome after intoxication with venlafaxin, lamotrigine and diazepam. Minerva Anesthesiol 2011; 77:93-5.
5. Ener RA, Meglathery SB, Van Decker WA, Gallagher RM: Serotonin syndrome and other serotonergic disorders. Pain Medicine 2003; 4:63-74.
6. Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA: The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002; 441:137-40. (Pubitemid 34626163)
7. Kolecki P: Isolated venlafaxine-induced serotonin syndrome. J Emerg Med 1997; 15:491-3.
8. Lane R, Baldwin D: Selective serotonin reuptake inhibitor-induced serotonin syndrome: Review. J Clin Psychopharmacol 1997; 17:208-21. (Pubitemid 27261777)
9. Lange-Asschenfeldt C, Weigmann H, Hiemke C, Mann K: Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma-level correlated symptomatology. J Clin Pharmacol 2002; 22:440-1. (Pubitemid 34810341)
10. Stahl SM: Essential Psychopharmacology. The prescriber's guide. Cambridge University Press, Cambridge, 2005.
11. Stark AD, Jordan S, Allers KA, Bertekap RL, Chen R, Kannan TM, et al.: Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5HT2A receptors: functional receptor-binding and in vivo electrophysiological studies. Psychopharmacology 2007; 190:373-82. (Pubitemid 46155646)
12. Thase ME, Sloan DM: Venlafaxine and desvenlafaxine. In Schatzberg AF, Nemeroff CB (eds.): The American Psychiatric Publishing textbook of psychopharmacology. American Psychiatric Publishing, 2009.